A Review of the Current Status of Personalized Medicine for Lung Cancer in the AYA Population and Challenges in Improving Prognosis

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2026
This article has no abstract
Epistemonikos ID: 8346efeb3f0210c1ba0f868ea239fb07b64903ea
First added on: Oct 10, 2026